Famke Aeffner

Famke Aeffner

Auto-generated profile, based on publicly available information

Famke Aeffner

Amgen, Inc., South San Francisco, California, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in The Journal of Pathology
Verified
Journal Article
Open access
EAEsther Abels
Esther Abels
LPLiron Pantanowitz
Liron Pantanowitz
FAFamke Aeffner
Famke Aeffner
MZMark D Zarella
Mark D Zarella
JLJeroen van der Laak
Jeroen van der Laak
CKCleopatra Kozlowski
Cleopatra Kozlowski
In this white paper, experts from the Digital Pathology Association (DPA) define terminology and concepts in the emerging field of computational pathology, with a focus on its application to histology images analyzed together with their associated patient data to extract information. This review offers a historical perspective and describes the potential clinical benefits from research and applications in this field, as well as significant obstacles to adoption. Best practices for implementing computational pathology workflows are presented. These include infrastructure considerations, acquisition of training data, quality assessments, as well as regulatory, ethical, and cyber‐security concerns. Recommendations are provided for regulators, vendors, and computational pathology practitioners in order to facilitate progress in the field. © 2019 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

11 October 2018 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
MZMark D. Zarella
Mark D. Zarella
DBDouglas Bowman
Douglas Bowman
FAFamke Aeffner
Famke Aeffner
NFNavid Farahani
Navid Farahani
AXAlbert Xthona
Albert Xthona
DHDouglas J. Hartman
Douglas J. Hartman
Context.—: Whole slide imaging (WSI) represents a paradigm shift in pathology, serving as a necessary first step for a wide array of digital tools to enter the field. Its basic function is to digitize glass slides, but its impact on pathology workflows, reproducibility, dissemination of educational material, expansion of service to underprivileged areas, and intrainstitutional and interinstitutional collaboration exemplifies a significant innovative movement with far-reaching effects. Although the benefits of WSI to pathology practices, academic centers, and research institutions are many, the complexities of implementation remain an obstacle to widespread adoption. In the wake of the first regulatory clearance of WSI for primary diagnosis in the United States, some barriers to adoption have fallen. Nevertheless, implementation of WSI remains a difficult prospect for many institutions, especially those with stakeholders unfamiliar with the technologies necessary to implement a system or who cannot effectively communicate to executive leadership and sponsors the benefits of a technology that may lack clear and immediate reimbursement opportunity. Objectives.—: To present an overview of WSI technology—present and future—and to demonstrate several immediate applications of WSI that support pathology practice, medical education, research, and collaboration. Data Sources.—: Peer-reviewed literature was reviewed by pathologists, scientists, and technologists who have practical knowledge of and experience with WSI. Conclusions.—: Implementation of WSI is a multifaceted and inherently multidisciplinary endeavor requiring contributions from pathologists, technologists, and executive leadership. Improved understanding of the current challenges to implementation, as well as the benefits and successes of the technology, can help prospective users identify the best path for success.

1 January 2019 in Journal of Pathology Informatics
Verified
Journal Article
Open access
PDF file
FAFamke Aeffner
Famke Aeffner
MZMark D. Zarella
Mark D. Zarella
NBNathan Buchbinder
Nathan Buchbinder
MBMarilyn M. Bui
Marilyn M. Bui
MGMatthew R. Goodman
Matthew R. Goodman
DBDouglas Bowman
Douglas Bowman
The advent of whole-slide imaging in digital pathology has brought about the advancement of computer-aided examination of tissue via digital image analysis. Digitized slides can now be easily annotated and analyzed via a variety of algorithms. This study reviews the fundamentals of tissue image analysis and aims to provide pathologists with basic information regarding the features, applications, and general workflow of these new tools. The review gives an overview of the basic categories of software solutions available, potential analysis strategies, technical considerations, and general algorithm readouts. Advantages and limitations of tissue image analysis are discussed, and emerging concepts, such as artificial intelligence and machine learning, are introduced. Finally, examples of how digital image analysis tools are currently being used in diagnostic laboratories, translational research, and drug development are discussed.

30 May 2017 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
FAFamke Aeffner
Famke Aeffner
KWKristin Wilson
Kristin Wilson
NMNathan T. Martin
Nathan T. Martin
JBJoshua C. Black
Joshua C. Black
CHCris L. Luengo Hendriks
Cris L. Luengo Hendriks
GYG. Dave Young
G. Dave Young
Context.—: Novel therapeutics often target complex cellular mechanisms. Increasingly, quantitative methods like digital tissue image analysis (tIA) are required to evaluate correspondingly complex biomarkers to elucidate subtle phenotypes that can inform treatment decisions with these targeted therapies. These tIA systems need a gold standard, or reference method, to establish analytical validity. Conventional, subjective histopathologic scores assigned by an experienced pathologist are the gold standard in anatomic pathology and are an attractive reference method. The pathologist's score can establish the ground truth to assess a tIA solution's analytical performance. The paradox of this validation strategy, however, is that tIA is often used to assist pathologists to score complex biomarkers because it is more objective and reproducible than manual evaluation alone by overcoming known biases in a human's visual evaluation of tissue, and because it can generate endpoints that cannot be generated by a human observer. Objective.—: To discuss common visual and cognitive traps known in traditional pathology-based scoring paradigms that may impact characterization of tIA-assisted scoring accuracy, sensitivity, and specificity. Data Sources.—: This manuscript reviews the current literature from the past decades available for traditional subjective pathology scoring paradigms and known cognitive and visual traps relevant to these scoring paradigms. Conclusions.—: Awareness of the gold standard paradox is necessary when using traditional pathologist scores to analytically validate a tIA tool because image analysis is used specifically to overcome known sources of bias in visual assessment of tissue sections.

21 August 2015 in Toxicologic Pathology
Verified
Journal Article
Open access
FAFamke Aeffner
Famke Aeffner
BBBrad Bolon
Brad Bolon
IDIan C. Davis
Ian C. Davis
Acute respiratory distress syndrome (ARDS) is a severe pulmonary reaction requiring hospitalization, which is incited by many causes, including bacterial and viral pneumonia as well as near drowning, aspiration of gastric contents, pancreatitis, intravenous drug use, and abdominal trauma. In humans, ARDS is very well defined by a list of clinical parameters. However, until recently no consensus was available regarding the criteria of ARDS that should be evident in an experimental animal model. This lack was rectified by a 2011 workshop report by the American Thoracic Society, which defined the main features proposed to delineate the presence of ARDS in laboratory animals. These should include histological changes in parenchymal tissue, altered integrity of the alveolar capillary barrier, inflammation, and abnormal pulmonary function. Murine ARDS models typically are defined by such features as pulmonary edema and leukocyte infiltration in cytological preparations of bronchoalveolar lavage fluid and/or lung sections. Common pathophysiological indicators of ARDS in mice include impaired pulmonary gas exchange and histological evidence of inflammatory infiltrates into the lung. Thus, morphological endpoints remain a vital component of data sets assembled from animal ARDS models.

25 August 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
BBBrian Belmontes
Brian Belmontes
DSDeepali V. Sawant
Deepali V. Sawant
WZWendy Zhong
Wendy Zhong
HTHong Tan
Hong Tan
AKAnupurna Kaul
Anupurna Kaul
ONOlivier Nolan-Stevaux
Olivier Nolan-Stevaux
Immune checkpoint blockade and 4-1BB agonism overcome primary resistance to bispecific T cell engager therapy in T cell–cold solid tumors.